Krishna District, India

Srivatsa Koduru



Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Srivatsa Koduru

Introduction

Srivatsa Koduru, an accomplished inventor based in Krishna District, India, has made significant contributions to the field of biochemistry through a groundbreaking patent. His innovative work has the potential to greatly enhance the analysis and understanding of insulin and its analogues.

Latest Patents

Koduru holds a singular patent titled "Peptide mapping method for sequence identification of insulin and insulin analogues". This invention is centered around a peptide mass fingerprinting technique that allows for the identification of proteins, specifically Human insulin and various insulin analogs. Notably, the method is adept at distinguishing insulin analogues that differ by at least one amino acid, a challenge that current analytical methods have struggled to overcome. The patented method also allows for the confirmation of peptide sequences within a runtime of forty minutes and is applicable to molecules weighing up to 50 kDa.

Career Highlights

Currently, Srivatsa Koduru is associated with Biocon Limited, a prominent biotechnology company recognized for its innovations in the healthcare domain. His role at the company has been instrumental in advancing drug development and biopharmaceutical research.

Collaborations

In the pursuit of his research and patent endeavors, Koduru has collaborated with notable colleagues, including Phanichand Kodali and Krishnappa Mane. These partnerships highlight the importance of teamwork in scientific discovery and innovation.

Conclusion

Srivatsa Koduru's innovative contributions to peptide mapping and insulin analysis exemplify the impact of dedicated inventors on healthcare and biotechnology. With his patented technique, the challenges previously faced in distinguishing insulin analogues can be effectively addressed, marking a significant advancement in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…